Results 91 to 100 of about 500,219 (165)

Self-administered contraceptive subcutaneous MPA

open access: yes, 2021
DMPA-SC is a lower-dose, easy-to-use injectable contraceptive. A trained person can administer it, including women through self-injection. This systematic review aims to assess the effectiveness of self- versus provider-administered contraceptive DMPA-SC
Farida Elshafeey   +4 more
core   +1 more source

Integrating Sexual and Reproductive Health Self-Care Interventions in Sub-Saharan Africa: A Systematic Review

open access: yesHealth Research in Africa
Self‑care interventions are increasingly recognized as critical for advancing sexual and reproductive health and rights (SRHR) in Africa, particularly among adolescents and young people (AYP) aged 10–24 years.
Zvanaka Sithole   +4 more
doaj   +1 more source

A longitudinal study examining how self-injection social norms are associated with contraceptive self-injectable interest and use in rural Uganda

open access: yesBMC Women's Health
Background There is mounting evidence that social norms affect attitudes, decision-making, and behaviors related to contraceptive use. Integral to the self-care movement for women to have more control over their reproductive health, subcutaneous depot ...
Erica Sedlander   +11 more
doaj   +1 more source

Self-administration of subcutaneous depot medroxyprogesterone acetate by adolescent women

open access: yes, 2013
Background: Intramuscular depot medroxyprogesterone acetate (DMPA-IM) is now available in subcutaneous (SC) formulation, potentially allowing for home-based self-administration.
Hensel, Devon J.   +2 more
core   +1 more source

CBD Profiles.xlsx

open access: yes, 2020
Pofiles for Community Based Distributors who participated in the introduction of DMPA-SC pilot in ...
Hastings Moono (8428986)
core   +1 more source

Introducing the subcutaneous depot medroxyprogesterone acetate injectable contraceptive via social marketing: lessons learned from Nigeria's private sector. [PDF]

open access: yes, 2018
ObjectivesThe subcutaneous depot medroxyprogesterone acetate (DMPA-SC) injectable contraceptive was introduced in South West Nigeria in 2015 through private sector channels.
Erinfolami, Temitope   +14 more
core   +1 more source

DMPA injectable use: Findings from the 21-month DMPA monitoring study [PDF]

open access: yes, 1996
This report presents the results of the DMPA Monitoring Study undertaken by the Population Council, Manila, as a technical assistance project for the DMPA Reintroduction Program of the Department of Health.
Population Council, null null
core   +1 more source

Expectations and Experiences of Side Effects Among Adolescent Women Using Intramuscular and Subcutaneous Depot Medroxyprogesterone Acetate [PDF]

open access: yes, 2010
Background: Intramuscular depot medroxyprogesterone acetate (DMPA-IM) has known physical side effects including changes in bleeding. A lower dose, subcutaneous formulation (DMPA-SC) is available with a similar side effect profile among adult women ...
Tanner, Amanda Elizabeth   +1 more
core  

Average Stratum Corneum (SC) Thickness of the Ectocervix and Vagina of Rhesus and Pigtail Macaques.

open access: yes, 2016
Menstrual cycle phases were designated as follicular (day 1 of menstruation until day 14), midcycle (days 14–16), or luteal (days 17 to day prior to menstruation).
Thomas J. Hope (108657)   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy